Please select disease or vaccine
Ask 8 Information Kiosk

Explore FREE downloadable educational materials.

Connect with us!

Report Your Vaccine Experiences

Read and report vaccine reactions, harassment and failures. 

NVIC Press Releases, Statements & Commentaries Related to Rubella

Updated February 09, 2023


NVIC’s Website

The Vaccine Reaction

Bibliography & Resource Links 


Institute of Medicine Committee. Adverse Effects of Pertussis and Rubella Vaccines The National Academies Press 1991.

Institute of Medicine Committee. Evaluating Biological Mechanisms for Adverse Events: Increased Susceptibility. In: Adverse Effects of Vaccines: Evidence and Causality. The National Academies Press 2012.

LeBaron CW, Forghani B, Matter L et al. Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine. J Infect Dis Sep. 2009; 200(6):888-99.

Demicheli V, Rivetti A, Debalini MG, et al. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev Feb. 2012; (2):CD004407.

McLean HQ, Fiebelkorn AP, Ogee-Nwankwo A et al. Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adults. Vaccine Sept. 2018; 36(38):5732-5737.

Haralambieva IH, Ovsyannikova IG, Kennedy RB et al. Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age. Vaccine Jan 2020; 38(5):1249-1257.

IMPORTANT NOTE: NVIC encourages you to become fully informed about Rubella and the Rubella vaccine by reading all sections in the Table of Contents, which contain many links and resources such as the manufacturer product information inserts, and to speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child. This information is for educational purposes only and is not intended as medical advice.

 


Opens in new tab, window
Opens an external site
Opens an external site in new tab, window